Cimon Medical exists to innovate life saving solutions. We do this by developing and manufacturing Doppler ultrasound technology for health care facilities. Our first product, NeoDoppler, provides non-invasive continuous blood flow monitoring for infants.
To reduce neonatal mortality and the risk of neurodevelopmental damage, there is a strong need for improved monitoring of brain circulation during birth, resuscitation and intensive care treatment. But no adequate solution has been available – until now.
Our technology originates from the world-renowned ultrasound environment at The Norwegian University of Science and Technology (NTNU) and St. Olavs University Hospital, in Trondheim, Norway.
Here it was invented by Professor Hans Torp and Pediatric Cardiologist Siri Ann Nyrnes, who are both driving forces in the local ultrasound community.
Doppler Ultrasound for clinical use is developed at the internationally renowned Department of Circulation and Imaging at the Norwegian Technical University (NTNU) in Trondheim, Norway
Pilot- and clinical studies with prototypes initiated at St.Olavs and Oslo Univ. Hospital
Launch of 1st regulatory approved product – NeoDoppler
Idea and concept for Cimon technology developed by Prof. Hans Torp
Industrialization process with selected manufacturing partners
Senior executive with +35 years of Medical device experience within Sales, R&D, Operations and Leadership. Been working with customers and facilities in USA and EU, Asia-Pacific and Mexico. Created long term partnerhips with major blue chip companies.
Professor in medical technology at the Department of Circulation and Medical Imaging, NTNU. More than 40 years of experience in research and development of ultrasound Doppler technology and have received several awards for his work.
Consultant pediatric cardiologist at the pediatric department, St. Olavs hospital and researcher at the Department of Circulation and Medical Imaging, NTNU. Project leader of the NeoDoppler research, responsible for the clinical verification.
Experienced in sales within the Scandinavian health care industry, with 10+ years of experience as a qualified nurse in Danish hospitals. Passionate about improving standard of care for preterm infants. Sales manager for Cimon Medical in the Nordics and Europe, and responsible for onboarding hospitals in the use of NeoDoppler.
Multi-disciplinary technical background on product development and industrialization within electronics, mechanics and software. Experienced business developer from setting up several research-based startup companies from NTNU.
Chief Software Architect
Experienced full-stack software developer and architect from multiple start-up companies, with a strong user focus. Have led development of medical software applications to CE and FDA approval.
Professor in cardiology at the Department of Circulation and Medical Imaging, NTNU and professor in prehospital medicine at Faculty of Nursing and Health Sciences, Nord University and Consultant cardiologist and specialist in anesthesia and intensive care medicine. Project leader of the RescueDoppler research.
Senior Software Developer
Full-stack software developer. More than 20 years’ experience as a software developer, mainly in the medical technology field. Developed imaging and analysis software for medical ultrasound in echocardiography, vascular and neurology. Several patents in echocardiography.
15 years of experience from Research and Development of ultrasound Doppler systems, starting with a PhD on 3D Doppler ultrasound for leaky heart valves. Several Doppler-related patents and patents pending. Ultrasound Systems specialist with detailed knowledge of the full ultrasound stack, from acoustics through hardware, signal processing and applications. Co-Inventor of the core technology patent of Cimon.
Experienced financial strategist with background from several technology-based start-ups og scale-ups. An active member of the board in several companies, with 15+ years of experience from helping tech innovation companies reach their full potential.
St.Olavs Hospital collaborates closely with NTNU on education and has a special responsibility for sharing knowledge and supporting professional development in the specialist health services in central Norway.
The regional hospital is responsible for the most specialized treatment services, and therefore has patients throughout central Norway. St. Olavs Hospital also has some national functions and collaborates with other university hospitals.
NTNU is Norway’s university for higher ed- ucation in technology and natural sciences.
NTNU has 9 faculties and 55 institutes and more than 100 laboratories. The university employs approximately 5360 academic staff and has 40 000 students.
The university is recognized for a broad cooperation with national and international businesses and has an annual budget of approx. 9 billion Norwegian kroner.
NTNU Technology Transfer AS works to create value from research based ideas that come out of The Norwegian University of Science and Technology (NTNU) and The Central Norway Regional Health Authority (Helse Midt-Norge).
NTNU Technology Transfers goal is to create benefit to society from these ideas in the form of new products, new services, new industries and new jobs.